Table 1:

Clinical characteristics and imaging findings of patients with low- and high-grade stenotic basilar artery plaque

All (n = 126)Low-Grade Stenosis (<50%, n = 46)High-Grade Stenosis (≥50%, n = 80)P Value
Age (mean) (yr)61.5 ± 10.063.70 ± 9.460.3 ± 10.1.07
Sex (male) (No.) (%)82 (65.1%)33 (71.7%)49 (61.3%).23
Diabetes (No.) (%)42 (33.3%)15 (32.6%)27 (33.8%).90
Smoking (No.) (%)35 (27.8%)13 (28.3%)22 (27.5%).93
Hypertension (No.) (%)101 (80.2%)37 (80.4%)64 (80.0%).96
Hyperlipidemia (No.) (%)65 (51.6%)18 (39.1%)47 (58.8%).03a
Coronary artery disease (No.) (%)5 (4.0%)3 (6.5%)2 (2.5%).27
Preadmission aspirin use (No.) (%)31 (24.6%)9 (19.6%)22 (27.5%).32
Preadmission statin use (No.) (%)17 (13.5%)4 (8.7%)13 (16.3%).23
NIHSS score (median) (range)1 (0–11)2 (0–11)0 (0–6)<.001a
Degree of stenosis (mean) (%)52.6 ± 15.835.2 ± 9.762.6 ± 7.9<.001a
Enhancement percentage (mean)17.4 ± 28.421.1 ± 33.115.3 ± 25.3.27
Intraplaque hemorrhage (No.) (%)22 (17.5%)9 (19.6%)13 (16.3%).63
Minimum lumen area (mean) (mm2)3.2 ± 2.75.1 ± 3.42.1 ± 1.3<.001a
Plaque burden (mean) (%)84.0 ± 9.175.9 ± 8.288.6 ± 5.7<.001a
Symptomatic (No.) (%)66 (52.4%)28 (60.9%)38 (47.5%).15
  • a Statistically significant.